Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
DNA X, Inc.
Report date July 13, 2022 · Filed July 15, 2022
Section 16 reporting ended · disclosed 2022-07-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 314,619 |
Ending reported balance
After 2022-07-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-07-13 · Sale · Disposed 9,176 · Balance 315,348 F1: Represents shares sold by the Reporting Person pursuant to a mandatory sale provision of the relevant restricted share unit ("RSU") grant requiring the sale of sufficient shares to cover withholding taxes upon vesting of RSUs. Row 2 · 2022-07-15 · Sale · Disposed 729 · Balance 314,619 F1: Represents shares sold by the Reporting Person pursuant to a mandatory sale provision of the relevant restricted share unit ("RSU") grant requiring the sale of sufficient shares to cover withholding taxes upon vesting of RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares sold by the Reporting Person pursuant to a mandatory sale provision of the relevant restricted share unit ("RSU") grant requiring the sale of sufficient shares to cover withholding taxes upon vesting of RSUs.
Resonant Inc
Report date March 28, 2022 · Filed March 28, 2022
Section 16 reporting ended · disclosed 2022-03-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-03-28 transaction · row 1
1 source rowRow 1 · 2022-03-28 · Other · Disposed 64,184 · Balance 0 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-03-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-03-28 · Disposition to issuer · Disposed 35,000 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F2: In connection with the Agreement and Plan of Merger, dated February 14, 2022, by and among Murata Electronics North America, Inc., PJ Cosmos Acquisition Company, Inc. and Resonant Inc. (the "Merger Agreement"), these restricted stock units, which provided for vesting of 50% of the shares on each of May 10, 2022 and May 10, 2023, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-03-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-03-28 · Disposition to issuer · Disposed 12,711 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F3: In connection with the Merger Agreement, these restricted stock units, which provided for vesting of the shares on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 9, 2022, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-03-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-03-28 · Disposition to issuer · Disposed 19,788 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F4: In connection with the Merger Agreement, these restricted stock units, which provided for vesting of 50% of the shares on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 8, 2022, and 50% of the shares on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 8, 2023, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock.
F2: In connection with the Agreement and Plan of Merger, dated February 14, 2022, by and among Murata Electronics North America, Inc., PJ Cosmos Acquisition Company, Inc. and Resonant Inc. (the "Merger Agreement"), these restricted stock units, which provided for vesting of 50% of the shares on each of May 10, 2022 and May 10, 2023, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash.
F3: In connection with the Merger Agreement, these restricted stock units, which provided for vesting of the shares on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 9, 2022, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash.
F4: In connection with the Merger Agreement, these restricted stock units, which provided for vesting of 50% of the shares on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 8, 2022, and 50% of the shares on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 8, 2023, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2022 Filed Jul 15, 2022 23:40 UTC | DNA X, Inc. SONM · Entity 8261 | SaleCommon Stock | 729 | $0.76 | $553.09 |
DisclosureSEC source: 0000899243-22-026172 · doc4.xml · nonDerivative · entry 2 TIRVA ROBERT L. · CIK 0001438223 · Former President, CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,619 F1 · shares: Represents shares sold by the Reporting Person pursuant to a mandatory sale provision of the relevant restricted share unit ("RSU") grant requiring the sale of sufficient shares to cover withholding taxes upon vesting of RSUs. Read SEC document |
| July 13, 2022 Filed Jul 15, 2022 23:40 UTC | DNA X, Inc. SONM · Entity 8261 | SaleCommon Stock | 9,176 | $0.54 | $4,988.07 |
DisclosureSEC source: 0000899243-22-026172 · doc4.xml · nonDerivative · entry 1 TIRVA ROBERT L. · CIK 0001438223 · Former President, CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315,348 F1 · shares: Represents shares sold by the Reporting Person pursuant to a mandatory sale provision of the relevant restricted share unit ("RSU") grant requiring the sale of sufficient shares to cover withholding taxes upon vesting of RSUs. Read SEC document |
| June 21, 2022 Filed Jun 22, 2022 20:13 UTC | DNA X, Inc. SONM · Entity 8261 | SaleCommon Stock | 10,361 | $0.54 | $5,594.94 |
DisclosureSEC source: 0000899243-22-023558 · doc4.xml · nonDerivative · entry 1 TIRVA ROBERT L. · CIK 0001438223 · President, CFO and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,524 F1 · shares: Represents shares sold by the Reporting Person pursuant to a mandatory sale provision of the relevant restricted share unit ("RSU") grant requiring the sale of sufficient shares to cover withholding taxes upon vesting of RSUs. F2 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $0.54 to $0.5414, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: Includes 32,124 RSUs. Each RSU represents the right to receive one share of the Issuer's common stock. Read SEC document |
| June 10, 2022 Filed Jun 13, 2022 21:38 UTC | DNA X, Inc. SONM · Entity 8261 | SaleCommon Stock | 4,493 | $0.58 | $2,583.48 |
DisclosureSEC source: 0000899243-22-022227 · doc4.xml · nonDerivative · entry 1 TIRVA ROBERT L. · CIK 0001438223 · President, CFO and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334,885 F1 · shares: Represents shares sold by the Reporting Person pursuant to a mandatory sale provision of the relevant restricted share unit ("RSU") grant requiring the sale of sufficient shares to cover withholding taxes upon vesting of RSUs. F2 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $0.57 to $0.585, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: Includes 65,619 RSUs. Each RSU represents the right to receive one share of the Issuer's common stock. Read SEC document |
| March 28, 2022 Filed Mar 28, 2022 13:42 UTC | Resonant Inc RESN · Entity 128713 | Disposition to issuerRestricted Stock Units · Derivative | 19,788 | $4.50 | $89,046.00 |
DisclosureSEC source: 0001104659-22-038602 · tm2210529-6_4seq1.xml · derivative · entry 4 TIRVA ROBERT L. · CIK 0001438223 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,788 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F4 · derivative.exercise_date: In connection with the Merger Agreement, these restricted stock units, which provided for vesting of 50% of the shares on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 8, 2022, and 50% of the shares on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 8, 2023, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash. F4 · derivative.expiration_date: In connection with the Merger Agreement, these restricted stock units, which provided for vesting of 50% of the shares on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 8, 2022, and 50% of the shares on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 8, 2023, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash. Read SEC document |
| March 28, 2022 Filed Mar 28, 2022 13:42 UTC | Resonant Inc RESN · Entity 128713 | Disposition to issuerRestricted Stock Units · Derivative | 12,711 | $4.50 | $57,199.50 |
DisclosureSEC source: 0001104659-22-038602 · tm2210529-6_4seq1.xml · derivative · entry 3 TIRVA ROBERT L. · CIK 0001438223 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,711 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F3 · derivative.exercise_date: In connection with the Merger Agreement, these restricted stock units, which provided for vesting of the shares on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 9, 2022, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash. F3 · derivative.expiration_date: In connection with the Merger Agreement, these restricted stock units, which provided for vesting of the shares on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 9, 2022, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash. Read SEC document |
| March 28, 2022 Filed Mar 28, 2022 13:42 UTC | Resonant Inc RESN · Entity 128713 | Disposition to issuerRestricted Stock Units · Derivative | 35,000 | $4.50 | $157,500.00 |
DisclosureSEC source: 0001104659-22-038602 · tm2210529-6_4seq1.xml · derivative · entry 2 TIRVA ROBERT L. · CIK 0001438223 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F2 · derivative.exercise_date: In connection with the Agreement and Plan of Merger, dated February 14, 2022, by and among Murata Electronics North America, Inc., PJ Cosmos Acquisition Company, Inc. and Resonant Inc. (the "Merger Agreement"), these restricted stock units, which provided for vesting of 50% of the shares on each of May 10, 2022 and May 10, 2023, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash. F2 · derivative.expiration_date: In connection with the Agreement and Plan of Merger, dated February 14, 2022, by and among Murata Electronics North America, Inc., PJ Cosmos Acquisition Company, Inc. and Resonant Inc. (the "Merger Agreement"), these restricted stock units, which provided for vesting of 50% of the shares on each of May 10, 2022 and May 10, 2023, were assumed and converted in the merger into a right of the holder to receive upon settlement an amount in cash equal to the per share merger consideration of $4.50 multiplied by the number of shares of common stock subject to such restricted stock units immediately prior to the merger. Upon the resignation of holder as a director of Resonant Inc. immediately following consummation of the merger, these assumed restricted stock units became fully vested and will be settled in cash. Read SEC document |
| March 28, 2022 Filed Mar 28, 2022 13:42 UTC | Resonant Inc RESN · Entity 128713 | OtherCommon Stock | 64,184 | $4.50 | $288,828.00 |
DisclosureSEC source: 0001104659-22-038602 · tm2210529-6_4seq1.xml · nonDerivative · entry 1 TIRVA ROBERT L. · CIK 0001438223 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 21:07 UTC | DNA X, Inc. SONM · Entity 8261 | GrantCommon Stock | 233,638 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-003634 · doc4.xml · nonDerivative · entry 1 TIRVA ROBERT L. · CIK 0001438223 · President, CFO and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,378 F1 · balance_after: The amount of securities reported in this Form 4 as beneficially owned by the Reporting Person reflects adjustments made in connection with a 1-for-10 reverse stock split of the Issuer's common stock on September 15, 2021. F2 · balance_after: Includes 1,250 shares of the Issuer's common stock that were purchased by the Reporting Person under the Issuer's employee stock purchase plan since the last filing of a Form 4 by the Reporting Person. Read SEC document |
| September 10, 2021 Filed Sep 15, 2021 01:00 UTC | DNA X, Inc. SONM · Entity 8261 | SaleCommon Stock | 6,417 | $0.67 | $4,299.39 |
DisclosureSEC source: 0000899243-21-035919 · doc4.xml · nonDerivative · entry 1 TIRVA ROBERT L. · CIK 0001438223 · President, CFO and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,044,889 F1 · shares: Represents shares sold by the Reporting Person pursuant to a mandatory sale provision of the relevant restricted share unit ("RSU") grant requiring the sale of sufficient shares to cover withholding taxes upon vesting of RSUs. F2 · balance_after: Includes 795,702 restricted stock units. Read SEC document |
| June 18, 2021 Filed Jun 21, 2021 20:23 UTC | DNA X, Inc. SONM · Entity 8261 | GrantCommon Stock | 334,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001438223-21-000003 · primary_doc.xml · nonDerivative · entry 1 TIRVA ROBERT L. · CIK 0001438223 · President, CFO and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,051,306 F1 · shares: Represents the grant of restricted stock units that vest in one installment on June 18, 2022. Read SEC document |
| June 10, 2021 Filed Jun 12, 2021 01:30 UTC | DNA X, Inc. SONM · Entity 8261 | SaleCommon Stock | 42,891 | $0.64 | $27,450.24 |
DisclosureSEC source: 0000899243-21-023443 · doc4.xml · nonDerivative · entry 1 TIRVA ROBERT L. · CIK 0001438223 · President, CFO and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 716,354 F1 · shares: Represents shares sold by the Reporting Person pursuant to a mandatory sale provision of the relevant restricted share unit ("RSU") grant requiring the sale of sufficient shares to cover withholding taxes upon vesting of RSUs. F2 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $0.64 to $0.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: Includes (i) 481,875 RSUs and (ii) 10,380 and 11,691 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on November 13, 2020 and May 14, 2021, respectively. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 21:28 UTC | Resonant Inc RESN · Entity 128713 | GrantRestricted Stock Units · Derivative | 19,788 | $0.00 | $0.00 |
DisclosureSEC source: 0001438223-21-000002 · primary_doc.xml · derivative · entry 5 TIRVA ROBERT L. · CIK 0001438223 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,788 Underlying: Common Stock · 19,788 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F4 · derivative.exercise_date: 50% of the shares shall vest on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 8, 2022, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 8, 2023. F4 · derivative.expiration_date: 50% of the shares shall vest on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 8, 2022, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 8, 2023. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 21:28 UTC | Resonant Inc RESN · Entity 128713 | Exercise / conversionRestricted Stock Units · Derivative | 12,712 | $0.00 | $0.00 |
DisclosureSEC source: 0001438223-21-000002 · primary_doc.xml · derivative · entry 4 TIRVA ROBERT L. · CIK 0001438223 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,711 Underlying: Common Stock · 12,712 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F3 · derivative.exercise_date: 50% of the shares vested on June 7, 2021, and the remaining 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of the stockholders following the grant and (ii) June 9, 2022. F3 · derivative.expiration_date: 50% of the shares vested on June 7, 2021, and the remaining 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of the stockholders following the grant and (ii) June 9, 2022. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 21:28 UTC | Resonant Inc RESN · Entity 128713 | Exercise / conversionRestricted Stock Units · Derivative | 13,736 | $0.00 | $0.00 |
DisclosureSEC source: 0001438223-21-000002 · primary_doc.xml · derivative · entry 3 TIRVA ROBERT L. · CIK 0001438223 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,736 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F2 · derivative.exercise_date: 50% of the shares vested on June 8, 2020, and 50% of the shares vested on June 7, 2021. F2 · derivative.expiration_date: 50% of the shares vested on June 8, 2020, and 50% of the shares vested on June 7, 2021. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 21:28 UTC | Resonant Inc RESN · Entity 128713 | Exercise / conversionCommon Stock | 12,712 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001438223-21-000002 · primary_doc.xml · nonDerivative · entry 2 TIRVA ROBERT L. · CIK 0001438223 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 21:28 UTC | Resonant Inc RESN · Entity 128713 | Exercise / conversionCommon Stock | 13,736 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001438223-21-000002 · primary_doc.xml · nonDerivative · entry 1 TIRVA ROBERT L. · CIK 0001438223 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,472 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:09 UTC | Resonant Inc RESN · Entity 128713 | GrantRestricted Stock Units · Derivative | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001438223-21-000001 · primary_doc.xml · derivative · entry 1 TIRVA ROBERT L. · CIK 0001438223 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F2 · derivative.exercise_date: 50% of the shares shall vest on May 10, 2022, and 50% of the shares shall vest on May 10, 2023. F2 · derivative.expiration_date: 50% of the shares shall vest on May 10, 2022, and 50% of the shares shall vest on May 10, 2023. Read SEC document |
| October 07, 2020 Filed Oct 8, 2020 14:05 UTC | Resonant Inc RESN · Entity 128713 | Exercise / conversionRestricted Stock Units · Derivative | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001438223-20-000002 · primary_doc.xml · derivative · entry 2 TIRVA ROBERT L. · CIK 0001438223 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F2 · derivative.exercise_date: 12,000 shares vested on each of October 7, 2019 and October 7, 2020. F2 · derivative.expiration_date: 12,000 shares vested on each of October 7, 2019 and October 7, 2020. Read SEC document |
| October 07, 2020 Filed Oct 8, 2020 14:05 UTC | Resonant Inc RESN · Entity 128713 | Exercise / conversionCommon Stock | 12,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001438223-20-000002 · primary_doc.xml · nonDerivative · entry 1 TIRVA ROBERT L. · CIK 0001438223 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,736 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. Read SEC document |
| September 10, 2020 Filed Sep 14, 2020 22:52 UTC | DNA X, Inc. SONM · Entity 8261 | SaleCommon Stock | 7,826 | $0.86 | $6,695.14 |
DisclosureSEC source: 0001209191-20-050333 · doc4.xml · nonDerivative · entry 1 TIRVA ROBERT L. · CIK 0001438223 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 737,174 F1 · shares: Shares sold by Reporting Person pursuant to mandatory sale provision of the relevant restricted share unit ("RSU") grant requiring the sale of sufficient shares to cover withholding taxes upon vesting of RSUs. F2 · balance_after: Includes 621,375 RSUs Read SEC document |
| June 09, 2020 Filed Jun 10, 2020 21:36 UTC | Resonant Inc RESN · Entity 128713 | GrantRestricted Stock Units · Derivative | 25,423 | $0.00 | $0.00 |
DisclosureSEC source: 0001438223-20-000001 · primary_doc.xml · derivative · entry 3 TIRVA ROBERT L. · CIK 0001438223 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,423 Underlying: Common Stock · 25,423 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F3 · derivative.exercise_date: 50% of the shares shall vest on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 9, 2021, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 9, 2022. F3 · derivative.expiration_date: 50% of the shares shall vest on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 9, 2021, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 9, 2022. Read SEC document |
| June 09, 2020 Filed Jun 11, 2020 21:08 UTC | DNA X, Inc. SONM · Entity 8261 | PurchaseCommon Stock | 100,000 | $0.75 | $75,000.00 |
DisclosureSEC source: 0001209191-20-035993 · doc4.xml · nonDerivative · entry 3 TIRVA ROBERT L. · CIK 0001438223 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 745,000 F4 · shares: Represents shares of Common Stock purchased directly from the underwriters in an underwritten public offering conducted by the Issuer. Read SEC document |
| June 09, 2020 Filed Jun 11, 2020 21:08 UTC | DNA X, Inc. SONM · Entity 8261 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035993 · doc4.xml · nonDerivative · entry 2 TIRVA ROBERT L. · CIK 0001438223 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 645,000 F1 · shares: Represents the grant of restricted stock units that vest in four equal annual installments beginning on June 9, 2020. F3 · shares: This grant is contingent upon approval by the Issuer's stockholders of an increase in the number of shares reserved for issuance under the Issuer's 2019 Equity Incentive Plan. Read SEC document |
| June 09, 2020 Filed Jun 11, 2020 21:08 UTC | DNA X, Inc. SONM · Entity 8261 | GrantCommon Stock | 458,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035993 · doc4.xml · nonDerivative · entry 1 TIRVA ROBERT L. · CIK 0001438223 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 545,000 F1 · shares: Represents the grant of restricted stock units that vest in four equal annual installments beginning on June 9, 2020. F2 · balance_after: Includes 2,500 shares acquired by the reporting person under the Issuer's 2019 Employee Stock Purchase Plan on May 15, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 21:36 UTC | Resonant Inc RESN · Entity 128713 | Exercise / conversionRestricted Stock Units · Derivative | 13,736 | $0.00 | $0.00 |
DisclosureSEC source: 0001438223-20-000001 · primary_doc.xml · derivative · entry 2 TIRVA ROBERT L. · CIK 0001438223 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,736 Underlying: Common Stock · 13,736 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F2 · derivative.exercise_date: 50% of the shares vested on June 8, 2020, and the remaining 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of the stockholders following the grant and (ii) June 11, 2021. F2 · derivative.expiration_date: 50% of the shares vested on June 8, 2020, and the remaining 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of the stockholders following the grant and (ii) June 11, 2021. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 21:36 UTC | Resonant Inc RESN · Entity 128713 | Exercise / conversionCommon Stock | 13,736 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001438223-20-000001 · primary_doc.xml · nonDerivative · entry 1 TIRVA ROBERT L. · CIK 0001438223 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,736 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 23:01 UTC | DNA X, Inc. SONM · Entity 8261 | GrantStock Option (right to buy) · Derivative | 169,000 | $0.00 Strike: $2.26 | $0.00 |
DisclosureSEC source: 0001209191-19-055314 · doc4.xml · derivative · entry 2 TIRVA ROBERT L. · CIK 0001438223 · Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,000 Underlying: Common Stock · 169,000 shares Expires 2029-10-31 F2 · derivative.exercise_date: The option shall vest with respect to 25% of the underlying shares one year from September 9, 2019 and the remainder of the underlying shares shall vest in 1/48th monthly installments thereafter. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 23:01 UTC | DNA X, Inc. SONM · Entity 8261 | GrantCommon Stock | 84,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-055314 · doc4.xml · nonDerivative · entry 1 TIRVA ROBERT L. · CIK 0001438223 · Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,500 F1 · shares: Represents grant of restricted stock units that vest in four equal annual installments beginning September 9, 2019. Read SEC document |
| October 07, 2019 Filed Oct 8, 2019 20:23 UTC | Resonant Inc RESN · Entity 128713 | Exercise / conversionCommon Stock · Derivative | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001438223-19-000002 · primary_doc.xml · derivative · entry 2 TIRVA ROBERT L. · CIK 0001438223 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F2 · derivative.exercise_date: 12,000 shares vested on October 7, 2019, and 12,000 shares will vest on October 7, 2020. F2 · derivative.expiration_date: 12,000 shares vested on October 7, 2019, and 12,000 shares will vest on October 7, 2020. Read SEC document |
| October 07, 2019 Filed Oct 8, 2019 20:23 UTC | Resonant Inc RESN · Entity 128713 | Exercise / conversionCommon Stock | 12,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001438223-19-000002 · primary_doc.xml · nonDerivative · entry 1 TIRVA ROBERT L. · CIK 0001438223 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. Read SEC document |
| June 11, 2019 Filed Jun 12, 2019 21:04 UTC | Resonant Inc RESN · Entity 128713 | GrantRestricted Stock Units · Derivative | 27,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001438223-19-000001 · primary_doc.xml · derivative · entry 1 TIRVA ROBERT L. · CIK 0001438223 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,472 Underlying: Common Stock · 27,472 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F2 · derivative.exercise_date: 50% of the shares shall vest on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 11, 2020, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 11, 2021. F2 · derivative.expiration_date: 50% of the shares shall vest on the earlier of (i) the day prior to the first annual meeting of stockholders following the grant and (ii) June 11, 2020, and 50% of the shares shall vest on the earlier of (i) the day prior to the second annual meeting of stockholders following the grant and (ii) June 11, 2021. Read SEC document |
| October 14, 2018 Filed Oct 24, 2018 17:24 UTC | Resonant Inc RESN · Entity 128713 | GrantRestricted Stock Units · Derivative | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001438223-18-000004 · primary_doc.xml · derivative · entry 1 TIRVA ROBERT L. · CIK 0001438223 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Resonant Inc. common stock. F2 · derivative.exercise_date: The restricted stock units will vest in two equal installments of 12,000 shares on each of October 7, 2019 and October 7, 2020. F2 · derivative.expiration_date: The restricted stock units will vest in two equal installments of 12,000 shares on each of October 7, 2019 and October 7, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.